Prenatal and Newborn Genetic Testing Market Share, Size, and Outlook by 2031
Prenatal and Newborn Genetic Testing Market: Strategic Insights
Prenatal and Newborn Genetic Testing Market
-
CAGR (2023 - 2031)14.5% -
Market Size 2021
US$ 5.72 Billion -
Market Size 2031
US$ 21.44 Billion
Market Dynamics
GROWTH DRIVERS
- High Prevalence of Genetic Diseases in Infants
FUTURE TRENDS
- Government Support to Encourage Prenatal and Newborn Testing
OPPORTUNITIES
- Digital Microfluidics Poses a New Trend for the Newborn Screening
Key Players
- Abbott
- Quest Diagnostics Inc
- Bio Rad Laboratories Inc
- Illumina Inc
- F Hoffmann La Roche Ltd
- Qiagen
- PerkinElmer Inc
- Ravgen
- Natera Inc
- Laboratory Corporation of America Holdings
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product
- Diagnostic
- Screening
Disease Indication
- Cystic Fibrosis
- Sickle Cell Anaemia
- Down Syndrome
- Phenylketonuria
- Other Diseases
End User
- Hospitals & Clinics
- Diagnostic Centers
- Other End Users